88 related articles for article (PubMed ID: 3074917)
1. Residual B cell function in patients with long-standing NIDDM and its relation to metabolic control and diabetic complications.
Iwase M; Kikuchi M; Nunoi K; Maki Y; Wakisaka M; Wada M; Fujishima M
Endocrinol Jpn; 1988 Dec; 35(6):803-8. PubMed ID: 3074917
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
[TBL] [Abstract][Full Text] [Related]
3. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of beta cell function in non-insulin-dependent diabetes mellitus (NIDDM) and its correlations with clinico-metabolic parameters].
Santoro E; Gianni R; Maggi L; Tomassini CR; Bisacchi U
G Clin Med; 1989 Feb; 70(2):95-9. PubMed ID: 2666224
[TBL] [Abstract][Full Text] [Related]
5. Earlier appearance of impaired insulin secretion than of visceral adiposity in the pathogenesis of NIDDM. 5-Year follow-up of initially nondiabetic Japanese-American men.
Chen KW; Boyko EJ; Bergstrom RW; Leonetti DL; Newell-Morris L; Wahl PW; Fujimoto WY
Diabetes Care; 1995 Jun; 18(6):747-53. PubMed ID: 7555498
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic B-cell function in relation to diabetic retinopathy in Asian Indian NIDDM patients.
Snehalatha C; Mohan R; Mohan V; Ramachandran A; Viswanathan M
Acta Diabetol Lat; 1988; 25(2):95-100. PubMed ID: 3066087
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of beta-cell function estimates in non-insulin-dependent diabetes mellitus.
Gjessing HJ; Damsgaard EM; Matzen LE; Frøland A; Faber OK
Diabetes Care; 1987; 10(5):558-62. PubMed ID: 3315512
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.
Hendriksen C; Faber OK; Drejer J; Binder C
Diabetologia; 1977 Dec; 13(6):615-9. PubMed ID: 338408
[TBL] [Abstract][Full Text] [Related]
9. Fasting plus prandial insulin supplements improve insulin secretory ability in NIDDM subjects.
Kawamori R; Bando K; Yamasaki Y; Kubota M; Watarai T; Iwama N; Shichiri M; Kamada T
Diabetes Care; 1989; 12(10):680-5. PubMed ID: 2515048
[TBL] [Abstract][Full Text] [Related]
10. Residual B-cell function in insulin-dependent (type I) diabetics with and without retinopathy.
Sberna P; Valentini U; Cimino A; Sabatti MC; Rotondi A; Crisetig M; Spandrio S
Acta Diabetol Lat; 1986; 23(4):339-44. PubMed ID: 3551428
[TBL] [Abstract][Full Text] [Related]
11. Abnormal glucose modulation of islet A- and B-cell responses to arginine in non-insulin-dependent diabetes mellitus.
Dimitriadis GD; Pehling GB; Gerich JE
Diabetes; 1985 Jun; 34(6):541-7. PubMed ID: 3891467
[TBL] [Abstract][Full Text] [Related]
12. Impact of family history of diabetes on the assessment of beta-cell function.
Alford FP; Henriksen JE; Rantzau C; Vaag A; Hew LF; Ward GM; Beck-Nielsen H
Metabolism; 1998 May; 47(5):522-8. PubMed ID: 9591741
[TBL] [Abstract][Full Text] [Related]
13. C-peptide response to glucagon in young diabetics.
Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
[TBL] [Abstract][Full Text] [Related]
14. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
Savage S; Estacio RO; Jeffers B; Schrier RW
Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
[TBL] [Abstract][Full Text] [Related]
15. Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.
Levy JC; Rudenski A; Burnett M; Knight R; Matthews DR; Turner RC
Diabetologia; 1991 Jul; 34(7):488-99. PubMed ID: 1916054
[TBL] [Abstract][Full Text] [Related]
16. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
Faber OK; Binder C
Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
[TBL] [Abstract][Full Text] [Related]
17. The beta-cell response to glucagon and mixed meal stimulation in non-insulin dependent diabetes.
Gjessing HJ; Damsgaard EM; Matzen LE; Faber OK; Frøland A
Scand J Clin Lab Invest; 1988 Dec; 48(8):771-7. PubMed ID: 3070718
[TBL] [Abstract][Full Text] [Related]
18. Relationship between autonomic cardiac activity, beta-cell function, anthropometrics and metabolic indices in type II diabetics.
Manzella D; Carbonella M; Ragno E; Passariello N; Grella R; Paolisso G
Clin Endocrinol (Oxf); 2002 Aug; 57(2):259-64. PubMed ID: 12153606
[TBL] [Abstract][Full Text] [Related]
19. C-peptide response to meal challenge in nondiabetic and diabetic adults living in Wadena, Minnesota.
Bushhouse SA; Goetz FC; Jacobs DR; Bender AP; French LR; Oestreich PG; Geisser MS
Diabetes Care; 1992 Oct; 15(10):1335-47. PubMed ID: 1425099
[TBL] [Abstract][Full Text] [Related]
20. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
